Ethicon Endo-Surgery, Inc.
USPTO PatentsView assignee record - 601 granted patents across 64 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Ethicon ranks #763 of 49,997 tracked US assignees by granted-patent volume, with 601 patents across 64 technology areas.
- #763
- of 49,997 US assignees by volume
- Top 5%
- by Innovation Score (58.0/100)
- 16.1
- avg claims per patent
- -97%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R763 · US Corporation #763 · 601 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-MID 601 grants
- TOP-DECILE #763/49,997
- PHOTO-FINISH Sunpower
- CPC-WIDE A61B · 64 areas
- INNOV-PAR 58.0/100
- CLAIMS-RICH 16.1 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -97% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Sunpower Corporation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Ethicon’s 58.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Ethicon
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Emerson Electric · near
Emerson Electric · near
58 score
- CornellCookson · near
CornellCookson · near
58 score
- Ethicon Endo-Surgery · this assignee
Ethicon Endo-Surgery · this assignee
58 score
- Open Text · near
Open Text · near
58 score
- Visera · near
Visera · near
58 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Ethicon's Innovation Score is 58.0/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Ethicon?
Each dot is one of Ethicon’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ethicon’s own 16.1 claims/patent is at or below the 16.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
How Ethicon's grant cadence moved
Between 2020–2024, Ethicon Endo-Surgery, Inc. received 17 grants versus 584 in 2015–2019 (-97% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 206 grants and bottomed in 2023 at 1. Lead class A61B accounts for 89.5% of the portfolio across 64 subclasses. Volume neighbours: Abb Vie Inc. (#759) and Bio-Rad Laboratories, Inc. (#767).
Ethicon's three-year grant acceleration
From 2019–2021 to 2022–2024, Ethicon Endo-Surgery, Inc. moved from 28 to 5 grants (0.18x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #3,119. See the growth leaderboard.
Who files at Ethicon's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Abb Vie
Abb Vie Inc.
604 patents
- SAS Institute
SAS Institute, Inc.
604 patents
- DIC
DIC Corporation
602 patents
- Maxlinear
MaxLinear, Inc.
602 patents
- Sunpower
Sunpower Corporation
601 patents
- Vitesco
Vitesco Technologies GMBH
601 patents
- Ethicon Endo-surg… ◀
Ethicon Endo-Surgery, Inc.
601 patents
- TDK Taiwan
TDK Taiwan Corp.
598 patents
- Bio-rad Laborator…
Bio-Rad Laboratories, Inc.
597 patents
What this shows Ethicon holds 601 patents at rank #763, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Ethicon
By rank, the assignees closest to #763 in granted patent volume.
- Abb Vie Inc. #759 · 604 patents
- SAS Institute, Inc. #760 · 604 patents
- DIC Corporation #761 · 602 patents
- MaxLinear, Inc. #762 · 602 patents
- Sunpower Corporation #764 · 601 patents
- Vitesco Technologies GMBH #765 · 601 patents
- TDK Taiwan Corp. #766 · 598 patents
- Bio-Rad Laboratories, Inc. #767 · 597 patents
Leaders in A61B (Diagnosis)
Other assignees with the most granted patents in Ethicon's primary technology class.
- Covidien LP 5,709 in class
- Koniniklijke Philips N.V. 3,414 in class
- Olympus Corporation 2,758 in class
- Boston Scientific Scimed, Inc. 2,362 in class
- Cilag GmbH International 2,063 in class
- Intuitive Surgical Operations, Inc. 1,921 in class
- DePuy Synthes Products, Inc. 1,796 in class
- Ethicon, Inc. 1,762 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Ethicon, neither rank-band nor same-CPC leaders (those blocks stay above). In A61B (Diagnosis), Ethicon ranks #29 of 7,127 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (58 here).
Similar claim depth
Nearest assignees by average claims per patent (16.1 here).
Ethicon's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
58 Top 5% higher than 95% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 206 | 34.3% |
| 2016 | 200 | 33.3% |
| 2017 | 119 | 19.8% |
| 2018 | 43 | 7.2% |
| 2019 | 16 | 2.7% |
| 2020 | 7 | 1.2% |
| 2021 | 5 | 0.8% |
| 2022 | 4 | 0.7% |
| 2023 | 1 | 0.2% |
Which technologies does Ethicon Endo-Surgery, Inc. patent most?
Top 15 of 64 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Ethicon Endo-Surgery, Inc.'s patent record in context - here's where to go next.
- Ethicon Endo-Surgery, Inc.'s lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 89.5% of its portfolio - see every assignee active in that class. Explore A61B
- Ranked #763 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Ethicon Endo-Surgery, Inc. against Abb Vie Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 58.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.